Who is sponsoring NCT03436940?

NCT03436940 is sponsored by A.O.U. Città della Salute e della Scienza.

What drugs are being tested in NCT03436940?

Interventions in NCT03436940: On Demand Discharge Planning (DDP), Routine Discharge Planning (RDP).

What condition does NCT03436940 study?

NCT03436940 studies Patient Discharge.

Is NCT03436940 still recruiting?

NCT03436940 is currently completed. Last updated 29 March 2022.

Last reviewed 2022-03-29 · How we verify

NCT03436940: PROMENADE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Two Strategies of Discharge Planning for the Reduction of Short Term Hospital Readmissions

Completed NA Last updated 29 March 2022

What this trial tests

NA trial testing On Demand Discharge Planning (DDP) in Patient Discharge in 802 participants. Completed in 13 October 2019.

Timeline

1 June 2018

Primary endpoint
12 October 2019

13 October 2019

Quick facts

Lead sponsor	A.O.U. Città della Salute e della Scienza
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	802
Start date	1 June 2018
Primary completion	12 October 2019
Estimated completion	13 October 2019
Sites	1 location across Italy

Drugs / interventions tested

On Demand Discharge Planning (DDP)
Routine Discharge Planning (RDP)

Conditions studied

Patient Discharge — all drugs for Patient Discharge →

Sponsor

A.O.U. Città della Salute e della Scienza — full company profile →

Who can join

18 and older, any sex, with Patient Discharge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to improve discharge planning effectiveness by comparing two strategies \[on-Demand Discharge Planning (DDP) vs. Routine Discharge Planning (RDP)\], in terms of reduction of hospital readmissions for inpatients classified at intermediate risk of complex discharge using the simplified Blaylock Risk Assessment Screening Score (BRASS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Routine vs. On-Demand Discharge Planning Strategy in Intermediate-Risk Patients for Complex Discharge: a Cluster-Randomized, Multiple Crossover Trial.
Evangelista A, Camussi E, Corezzi M, Gilardetti M, et al · · 2023 · cited 2× · PMID 37170018 · DOI 10.1007/s11606-023-08186-4

Verify or expand the search:

Other recruiting trials for Patient Discharge

Currently open trials in the same condition.

NCT06655337 — Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) · NA · recruiting
NCT06737393 — Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge · NA · recruiting

Other A.O.U. Città della Salute e della Scienza trials

Trials by the same sponsor.

NCT07535125 — IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN · not yet recruiting
NCT07017192 — OPPOSED (anteriOr hiP arthroPlasty regiOnal aneSthEsia stuDy) Study · NA · recruiting
NCT06690567 — Clinical Outcomes of Contemporary IMPELLA Devices in Cardiogenic Shock and High-risk Percutaneous Coronary Intervention · unknown
NCT06548438 — The Impact of PDD During TURB for NMIBC · Phase 4 · not yet recruiting
NCT07245524 — PeriOPerative Spine Surgery COntrol Pain (POPSSCOP) Study: Intrathecal Morphine vs Erector Spinae Plane Block for Postop · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03436940 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by A.O.U. Città della Salute e della Scienza
Last refreshed: 29 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03436940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing